← Leaderboards
Russell O Pieper
University Of California San Francisco
$18,535,472
Attributed
$18,535,472
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$18,535,472 · 16
By mechanism
R01$10,789,655 · 9
P50$3,859,491 · 5
P01$2,868,842 · 1
T32$1,017,484 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- John P. Murnane$6,328,070
- Elissa S. Epel$23,864,091
- Synthia H Mellon$11,675,430
- Owen M. Wolkowitz$3,978,894
- Elizabeth H Blackburn$17,368,788
Others in their field
Top investigators on “Brain Neoplasms”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$98,312,615
- Gregory H Reaman · National Childhood Cancer Foundation$78,833,655
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- Robert H Vonderheide · University Of Pennsylvania$60,987,353
Research focus
Brain NeoplasmsBaseProgramsMonitorResearch PersonnelCellsPathway InteractionsFundingGliomaIn VitroIn VivoTumorGrantUnited States National Institutes Of HealthGeneticPilot ProjectsCollaborationsInstitutionResistanceResourcesScientistLinkNew TechnologyAward
Grant awards (72)
Understanding the novel action of PARPi in ALT-dependent tumors$369,431
R01 · FY2022 · CA · contact PI
Career Enhancement Program (CEP)$166,256
P50 · FY2022 · CA · contact PI
Developmental Research Program (DRP)$166,256
P50 · FY2022 · CA · contact PI
Contributions of IDH1 mutation to alternative lengthening of telomeres in lower-grade glioma$346,719
R01 · FY2021 · NS · contact PI
Developmental Research Program (DRP)$166,257
P50 · FY2021 · CA · contact PI
Career Enhancement Program (CEP)$166,256
P50 · FY2021 · CA · contact PI
Contributions of IDH1 mutation to alternative lengthening of telomeres in lower-grade glioma$346,719
R01 · FY2020 · NS · contact PI
Developmental Research Program (DRP)$164,815
P50 · FY2020 · CA · contact PI
Career Enhancement Program (CEP)$164,814
P50 · FY2020 · CA · contact PI
Contributions of IDH1 mutation to alternative lengthening of telomeres in lower-grade glioma$346,719
R01 · FY2019 · NS · contact PI
Developmental Research Program (DRP)$159,095
P50 · FY2019 · CA · contact PI
Career Enhancement Program (CEP)$159,093
P50 · FY2019 · CA · contact PI
Contributions of IDH1 mutation to alternative lengthening of telomeres in lower-grade glioma$346,719
R01 · FY2018 · NS · contact PI
Developmental Research Program (DRP)$178,559
P50 · FY2018 · CA · contact PI
Career Enhancement Program (CEP)$178,558
P50 · FY2018 · CA · contact PI
Hyperpolarized 13C MRSI Monitoring of Pyruvate Metabolism to Assess Drug Action$609,543
P01 · FY2017 · CA · contact PI
Contributions of IDH1 mutation to alternative lengthening of telomeres in lower-grade glioma$346,719
R01 · FY2017 · NS · contact PI
Understanding the role of altered metabolism in gliomagenesis$328,888
R01 · FY2017 · CA · contact PI
DEVELOPMENTAL RESEARCH PROGAM$151,341
P50 · FY2017 · CA · contact PI
CAREER DEVELOPMENTAL PROGRAM$151,340
P50 · FY2017 · CA · contact PI
Hyperpolarized 13C MRSI Monitoring of Pyruvate Metabolism to Assess Drug Action$589,729
P01 · FY2016 · CA · contact PI
Understanding the role of altered metabolism in gliomagenesis$328,888
R01 · FY2016 · CA · contact PI
DEVELOPMENTAL RESEARCH PROGAM$129,779
P50 · FY2016 · CA · contact PI
CAREER DEVELOPMENTAL PROGRAM$129,779
P50 · FY2016 · CA · contact PI
Hyperpolarized 13C MRSI Monitoring of Pyruvate Metabolism to Assess Drug Action$579,889
P01 · FY2015 · CA · contact PI
Understanding the role of altered metabolism in gliomagenesis$328,456
R01 · FY2015 · CA · contact PI
DEVELOPMENTAL RESEARCH PROGAM$139,729
P50 · FY2015 · CA · contact PI
CAREER DEVELOPMENTAL PROGRAM$139,729
P50 · FY2015 · CA · contact PI
Hyperpolarized 13C MRSI Monitoring of Pyruvate Metabolism to Assess Drug Action$544,039
P01 · FY2014 · CA · contact PI
Understanding the role of altered metabolism in gliomagenesis$317,175
R01 · FY2014 · CA · contact PI
Training Program in Translational Brain Tumor Research$212,402
T32 · FY2014 · CA · contact PI
DEVELOPMENTAL RESEARCH PROGAM$133,659
P50 · FY2014 · CA · contact PI
CAREER DEVELOPMENTAL PROGRAM$133,658
P50 · FY2014 · CA · contact PI
Hyperpolarized 13C MRSI Monitoring of Pyruvate Metabolism to Assess Drug Action$545,642
P01 · FY2013 · CA · contact PI
Understanding the role of altered metabolism in gliomagenesis$325,343
R01 · FY2013 · CA · contact PI
A PTEN-regulated ubiquitin switch controlling TRAIL sensitivity in GBM$292,312
R01 · FY2013 · CA · contact PI
Training Program in Translational Brain Tumor Research$205,179
T32 · FY2013 · CA · contact PI
DEVELOPMENTAL RESEARCH PROGAM$135,754
P50 · FY2013 · CA · contact PI
CAREER DEVELOPMENTAL PROGRAM$135,753
P50 · FY2013 · CA · contact PI
A PTEN-regulated ubiquitin switch controlling TRAIL sensitivity in GBM$310,970
R01 · FY2012 · CA · contact PI
Training Program in Translational Brain Tumor Research$238,033
T32 · FY2012 · CA · contact PI
Developmental Research Program$59,988
P50 · FY2012 · CA · contact PI
A PTEN-regulated ubiquitin switch controlling TRAIL sensitivity in GBM$310,970
R01 · FY2011 · CA · contact PI
Training Program in Translational Brain Tumor Research$239,172
T32 · FY2011 · CA · contact PI
Developmental Research Program$136,811
P50 · FY2011 · CA · contact PI
A PTEN-regulated ubiquitin switch controlling TRAIL sensitivity in GBM$320,588
R01 · FY2010 · CA · contact PI
UNDERSTANDING TRAIL SENSITIVITY IN HUMAN GLIOMA$239,656
R01 · FY2010 · CA · contact PI
Developmental Research Program$146,664
P50 · FY2010 · CA · contact PI
Training Program in Translational Brain Tumor Research$122,698
T32 · FY2010 · CA · contact PI
A PTEN-regulated ubiquitin switch controlling TRAIL sensitivity in GBM$320,588
R01 · FY2009 · CA · contact PI
UNDERSTANDING TRAIL SENSITIVITY IN HUMAN GLIOMA$239,656
R01 · FY2009 · CA · contact PI
Developmental Research Program$149,936
P50 · FY2009 · CA · contact PI
P38, G2 Arrest, and Temozolomide Resistance in Gliomas$303,277
R01 · FY2008 · CA · contact PI
UNDERSTANDING TRAIL SENSITIVITY IN HUMAN GLIOMA$239,527
R01 · FY2008 · CA · contact PI
Developmental Research Program$158,277
P50 · FY2008 · CA · contact PI
P38, G2 Arrest, and Temozolomide Resistance in Gliomas$294,482
R01 · FY2007 · CA · contact PI
UNDERSTANDING TRAIL SENSITIVITY IN HUMAN GLIOMA$238,751
R01 · FY2007 · CA · contact PI
Developmental Research Program$157,335
P50 · FY2007 · CA · contact PI
Contributions of Akt to Glioblastoma Formation$329,166
R01 · FY2006 · CA · contact PI
P38, G2 Arrest, and Temozolomide Resistance in Gliomas$303,277
R01 · FY2006 · CA · contact PI
UNDERSTANDING TRAIL SENSITIVITY IN HUMAN GLIOMA$244,684
R01 · FY2006 · CA · contact PI
Contributions of Akt to Glioblastoma Formation$337,088
R01 · FY2005 · CA
P38, G2 Arrest, and Temozolomide Resistance in Gliomas$310,575
R01 · FY2005 · CA
Contributions of Akt to Glioblastoma Formation$337,088
R01 · FY2004 · CA
P38, G2 Arrest, and Temozolomide Resistance in Gliomas$310,575
R01 · FY2004 · CA
Contributions of Akt to Glioblastoma Formation$336,532
R01 · FY2003 · CA
Contributions of Akt to Glioblastoma Formation$334,028
R01 · FY2002 · CA
TRIGGERING OF ABERRANT CPG ISLAND METHYLATION$232,313
R01 · FY2002 · CA
TRIGGERING OF ABERRANT CPG ISLAND METHYLATION$232,313
R01 · FY2001 · CA
EXPRESSION AND SILENCING OF CPG ISLAND-CONTAINING GENES$205,428
R01 · FY2001 · CA
TRIGGERING OF ABERRANT CPG ISLAND METHYLATION$232,313
R01 · FY2000 · CA
EXPRESSION AND SILENCING OF CPG ISLAND-CONTAINING GENES$201,722
R01 · FY2000 · CA